CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    42

Stocks News & Analysis

stocks

Two cheap wide moat ASX shares

These shares are trading at a discount to our fair value discount and have sustainable competitive advantages.
stocks

Anthropic: Are the shares undervalued given the IPO pricing range?

There may be meaningful upside as Anthropic is pricing its stock as a reflection of current sentiment, not the company’s fundamentals.
stocks

Valuation looks stretched for ASX healthcare share

Strong fundamentals meet a demanding valuation.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,274.2017.10-0.18%
CAC 408,361.3628.490.34%
DAX 4026,771.88109.110.41%
Dow JONES (US)52,488.572.080.00%
FTSE 10010,863.0927.620.25%
HKSE24,008.55307.37-1.26%
NASDAQ25,410.8455.35-0.22%
Nikkei 22560,819.36429.23-0.70%
NZX 50 Index14,259.2379.370.56%
S&P 5007,612.247.14-0.09%
S&P/ASX 2009,146.806.40-0.07%
SSE Composite Index3,655.8324.81-0.67%

Market Movers